2022年4月29日 · This study demonstrated that the 52-mg LNG-IUS, initially approved for 5 years, maintains high contraceptive efficacy, user satisfaction, and a favorable safety profile through 8 years of use. The 3-year and individual yearly PIs and cumulative failure rate indicate that the 52-mg LNG-IUS remains highly effective throughout the whole period ...

LILETTA ® (levonorgestrel-releasing intrauterine system) 52 mg is a hormone-releasing system placed in your uterus to prevent pregnancy for up to 8 years. LILETTA also treats heavy periods for up to 5 years in women who choose to use birth control placed in the uterus.

2024年6月18日 · Levonorgestrel intrauterine system is used to prevent pregnancy. Mirena is also used to treat heavy menstrual bleeding in women who choose to use an intrauterine form of birth control. Levonorgestrel does not contain estrogen and …

The 52-mg LNG-IUS is an effective and cost-effective treatment option for idiopathic heavy menstrual bleeding. It improves quality of life and menstrual blood loss, and is well tolerated compared with endometrial ablation, hysterectomy, or usual medical therapies.

The levonorgestrel-releasing intrauterine system (LNG-IUS) is a safe, effective and acceptable form of contraception used by over 150 million women worldwide. It also has a variety of noncontraceptive benefits including treatment for menorrhagia, …

2024年7月18日 · Mirena (levonorgestrel-releasing intrauterine system) contains 52 mg of LNG, a progestin, and is intended to provide an initial release rate of LNG of approximately 21 mcg/day after 24 days.

2022年2月15日 · The levonorgestrel 52 mg IUS offers the longest duration of use of any hormonal intrauterine contraceptive from a single procedure, decreasing the need for removal and insertion procedures for longer contraceptive protection.

To assess the 5-year contraceptive efficacy and safety of a levonorgestrel (LNG) 52-mg intrauterine system (IUS) from an ongoing 10-year phase 3 contraceptive trial.

2020年11月5日 · Levosert® (EU)/Liletta® (USA) is a levonorgestrel (LNG)-releasing intrauterine system (IUS) containing 52 mg of LNG. It was the first LNG-releasing IUS approved for use for up to 6 years, with daily LNG release rates being sufficient …

2016年11月1日 · The 52-mg LNG-IUS is an effective and cost-effective treatment option for idiopathic heavy menstrual bleeding. It improves quality of life and menstrual blood loss, and is well tolerated compared with endometrial ablation, hysterectomy, or usual medical therapies.